Defining skin cancer local recurrence

Ashley Wysong, Shauna Higgins, Travis W. Blalock, Dominic Ricci, Rich Nichols, Franki Lambert Smith, Iren Kossintseva

Research output: Contribution to journalReview article

Abstract

Definitions of skin cancer recurrence are variable and nonstandardized, which can lead to inconsistent and potentially inappropriate management of tumors of uncertain recurrence status. Defining recurrence is important given the potential association with metastasis in both melanoma and nonmelanoma skin cancer. A review of the literature across multiple disciplines involved in the care of skin cancer patients reveals that although criteria for recurrence are provided in the majority of cases, most are vague and inconsistent. Given the presumably increased morbidity and mortality associated with recurrent tumors, accurate identification and appropriate management is paramount. In addition, value-based health care necessitates validated and relevant outcome measures that are standardized and, thus, enable tracking of comparable and corresponding outcomes. A universal definition of localized skin cancer recurrence would ultimately allow for improved surveillance and informed therapeutic strategies to decrease morbidity and mortality of patients afflicted with skin cancer, the most common cancer nationwide.

Original languageEnglish (US)
Pages (from-to)581-599
Number of pages19
JournalJournal of the American Academy of Dermatology
Volume81
Issue number2
DOIs
StatePublished - Aug 1 2019

Fingerprint

Skin Neoplasms
Recurrence
Morbidity
Neoplasms
Mortality
Melanoma
Outcome Assessment (Health Care)
Neoplasm Metastasis
Delivery of Health Care

Keywords

  • Mohs
  • melanoma
  • nonmelanoma skin cancer
  • recurrence
  • skin cancer

ASJC Scopus subject areas

  • Dermatology

Cite this

Wysong, A., Higgins, S., Blalock, T. W., Ricci, D., Nichols, R., Smith, F. L., & Kossintseva, I. (2019). Defining skin cancer local recurrence. Journal of the American Academy of Dermatology, 81(2), 581-599. https://doi.org/10.1016/j.jaad.2019.03.087

Defining skin cancer local recurrence. / Wysong, Ashley; Higgins, Shauna; Blalock, Travis W.; Ricci, Dominic; Nichols, Rich; Smith, Franki Lambert; Kossintseva, Iren.

In: Journal of the American Academy of Dermatology, Vol. 81, No. 2, 01.08.2019, p. 581-599.

Research output: Contribution to journalReview article

Wysong, A, Higgins, S, Blalock, TW, Ricci, D, Nichols, R, Smith, FL & Kossintseva, I 2019, 'Defining skin cancer local recurrence', Journal of the American Academy of Dermatology, vol. 81, no. 2, pp. 581-599. https://doi.org/10.1016/j.jaad.2019.03.087
Wysong A, Higgins S, Blalock TW, Ricci D, Nichols R, Smith FL et al. Defining skin cancer local recurrence. Journal of the American Academy of Dermatology. 2019 Aug 1;81(2):581-599. https://doi.org/10.1016/j.jaad.2019.03.087
Wysong, Ashley ; Higgins, Shauna ; Blalock, Travis W. ; Ricci, Dominic ; Nichols, Rich ; Smith, Franki Lambert ; Kossintseva, Iren. / Defining skin cancer local recurrence. In: Journal of the American Academy of Dermatology. 2019 ; Vol. 81, No. 2. pp. 581-599.
@article{a3308ba197ff4d17b82e09f817e1dac3,
title = "Defining skin cancer local recurrence",
abstract = "Definitions of skin cancer recurrence are variable and nonstandardized, which can lead to inconsistent and potentially inappropriate management of tumors of uncertain recurrence status. Defining recurrence is important given the potential association with metastasis in both melanoma and nonmelanoma skin cancer. A review of the literature across multiple disciplines involved in the care of skin cancer patients reveals that although criteria for recurrence are provided in the majority of cases, most are vague and inconsistent. Given the presumably increased morbidity and mortality associated with recurrent tumors, accurate identification and appropriate management is paramount. In addition, value-based health care necessitates validated and relevant outcome measures that are standardized and, thus, enable tracking of comparable and corresponding outcomes. A universal definition of localized skin cancer recurrence would ultimately allow for improved surveillance and informed therapeutic strategies to decrease morbidity and mortality of patients afflicted with skin cancer, the most common cancer nationwide.",
keywords = "Mohs, melanoma, nonmelanoma skin cancer, recurrence, skin cancer",
author = "Ashley Wysong and Shauna Higgins and Blalock, {Travis W.} and Dominic Ricci and Rich Nichols and Smith, {Franki Lambert} and Iren Kossintseva",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.jaad.2019.03.087",
language = "English (US)",
volume = "81",
pages = "581--599",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Defining skin cancer local recurrence

AU - Wysong, Ashley

AU - Higgins, Shauna

AU - Blalock, Travis W.

AU - Ricci, Dominic

AU - Nichols, Rich

AU - Smith, Franki Lambert

AU - Kossintseva, Iren

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Definitions of skin cancer recurrence are variable and nonstandardized, which can lead to inconsistent and potentially inappropriate management of tumors of uncertain recurrence status. Defining recurrence is important given the potential association with metastasis in both melanoma and nonmelanoma skin cancer. A review of the literature across multiple disciplines involved in the care of skin cancer patients reveals that although criteria for recurrence are provided in the majority of cases, most are vague and inconsistent. Given the presumably increased morbidity and mortality associated with recurrent tumors, accurate identification and appropriate management is paramount. In addition, value-based health care necessitates validated and relevant outcome measures that are standardized and, thus, enable tracking of comparable and corresponding outcomes. A universal definition of localized skin cancer recurrence would ultimately allow for improved surveillance and informed therapeutic strategies to decrease morbidity and mortality of patients afflicted with skin cancer, the most common cancer nationwide.

AB - Definitions of skin cancer recurrence are variable and nonstandardized, which can lead to inconsistent and potentially inappropriate management of tumors of uncertain recurrence status. Defining recurrence is important given the potential association with metastasis in both melanoma and nonmelanoma skin cancer. A review of the literature across multiple disciplines involved in the care of skin cancer patients reveals that although criteria for recurrence are provided in the majority of cases, most are vague and inconsistent. Given the presumably increased morbidity and mortality associated with recurrent tumors, accurate identification and appropriate management is paramount. In addition, value-based health care necessitates validated and relevant outcome measures that are standardized and, thus, enable tracking of comparable and corresponding outcomes. A universal definition of localized skin cancer recurrence would ultimately allow for improved surveillance and informed therapeutic strategies to decrease morbidity and mortality of patients afflicted with skin cancer, the most common cancer nationwide.

KW - Mohs

KW - melanoma

KW - nonmelanoma skin cancer

KW - recurrence

KW - skin cancer

UR - http://www.scopus.com/inward/record.url?scp=85068758432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068758432&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2019.03.087

DO - 10.1016/j.jaad.2019.03.087

M3 - Review article

VL - 81

SP - 581

EP - 599

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2

ER -